Table 3.
Postoperative POD prevalence and daily incidence
| Delirium incidence | PS (N = 23) | MS (N = 27) | MK (N = 24) | PK (N = 30) | p-value |
|---|---|---|---|---|---|
| Surgery night | 4 (17.39%) | 3 (11.11%) | 3 (12.5%) | 4 (13.33%) | 0.941 |
| 1 st day | 1 (4.35%) | 3 (11.11%) | 2 (8.33%) | 0 (0.0%) | 0.261 |
| 1 st night | 1 (4.35%) | 2 (7.41%) | 1 (4.17%) | 0 (0.0%) | 0.530 |
| 2nd day | 2 (8.7%) | 1 (3.7%) | 1 (4.17%) | 0 (0.0%) | 0.369 |
| 2nd night | 1 (4.35%) | 1 (3.7%) | 0 (0.0%) | 0 (0.0%) | 0.465 |
| 3rd day | 1 (4.35%) | 1 (3.7%) | 0 (0.0%) | 1 (3.33%) | 0.893 |
| 3rd night | 1 (4.35%) | 2 (7.41%) | 0 (0.0%) | 1 (3.33%) | 0.730 |
| 4th day | 1 (4.35%) | 0 (0.0%) | 0 (0.0%) | 1 (3.33%) | 0.718 |
| 4th night | 1 (4.35%) | 0 (0.0%) | 0 (0.0%) | 1 (3.33%) | 0.718 |
|
Prevalence (95% exact confidence interval) |
4 (17.39%) (4.95–38.78%) |
6 (22.23%) (8.62–42.26%) |
4 (16.67%) (4.74–37.38%) |
5 (16.67%) (5.64–34.72%) |
0.957 |
PS, placebo-saline; MS, melatonin-saline; MK, melatonin-ketamine; PK, placebo-saline